Introduction {#section5-2382120519894253}
============

Medical knowledge of biological sex differences as well as the awareness of socially constructed characteristics of the individual (gender) are recommended to use for diagnosis and therapy in daily clinical practice. Therefore, sex- and gender-based medicine (SGBM), as an integral component of patient-centered medicine, should be a mandatory part of medical education and national medical exams.^[@bibr1-2382120519894253],[@bibr2-2382120519894253]^

Based on the definition of "sex and gender" used by the Canadian Institutes of Health Research (CIHR) and the Institute of Gender in Medicine in Germany, "gender" is a psychosocial construct comprising four main features: gender roles, gender identity, gender relations, and institutionalized gender. "Sex" refers to a set of biological attributes in humans and animals. It is primarily associated with physiological features including chromosomes, gene expression, hormone levels and function, and reproductive/sexual anatomy.^[@bibr3-2382120519894253],[@bibr4-2382120519894253]^ Neither sex nor gender should be looked at solely due to their reciprocal influence of each other, and their joint impact on health.^[@bibr5-2382120519894253]^ The study by Pelletier et al.^[@bibr6-2382120519894253]^ laid the groundwork for the objective measurement of gender. This new ability to quantify the effect size of gender aspects in studies will lead to much more knowledge about the risk factors that contribute to the onset of disease.

Incorporation and translation of new facts based on sex and gender research into educational programs is challenging though.^[@bibr7-2382120519894253],[@bibr8-2382120519894253]^ While medical curricula vary widely between universities, all medical students take nationwide standardized examinations, which therefore function as indicators for the governmental framework regarding the implementation of SGBM into medical education. Neither the German nor the American regulatory guidelines on medical licensing explicitly incorporate sex- or gender-based aspects in their learning outcomes apart from reproductive aspects and sexual disorders.^[@bibr9-2382120519894253][@bibr10-2382120519894253]-[@bibr11-2382120519894253]^

To examine the extent of the implementation of SGBM and therefore the students' sex- and gender-related medical knowledge, this study analyzes the learning material used to prepare for standardized national medical exams. All German medical students take the German state examination, a 3-day written, multiple-choice exam, at the end of their fifth year at university and before entering the 1-year clinical internship. The American counterpart with a comparable scope and value, the USMLE Step 1, is a 1-day written, multiple-choice exam, most medical students take at the end of their second year in medical school.

This study analyzes the e-learning materials of AMBOSS 2017 (<https://amboss.miamed.de>), a web-based knowledge platform used by 95% of German medical students to prepare for the German state examination,^[@bibr12-2382120519894253]^ and of USMLE Step 1 Lecture Notes (2017), an e-book series by KAPLAN MEDICAL, one of the leading companies in the test prep industry, and used by thousands of American students,^[@bibr13-2382120519894253]^ to test the hypothesis that the preparatory materials for the German and the American national medical exams incorporate sex- and gender-related content based on the already published scientific knowledge and that German and American medical students are therefore equally well prepared in the field of SGBM.

Methods {#section6-2382120519894253}
=======

AMBOSS is a continuously updated, web-based knowledge platform, offering, inter alia, a comprehensive set of learning cards that cover the topics tested in the German state examination. The annually revised KAPLAN e-book series comprises seven volumes, each tailored for an examination subject of the USMLE Step 1. The subjects included in the analysis were allocated to one of the 3 main fields: *clinical subjects, behavioral and social science*, and *pharmacology*. To increase comparability, subjects specific to only one of the learning resources were not included in the analysis.

For a systematic analysis of sex- and gender-related content, a last year medical student who has been trained in sex and gender medicine for 3 years at the Institute for Gender in Medicine at Charité---Universitaetsmedizin Berlin performed a line-by-line analysis of the preparatory materials between April and October 2017 and was observed by a senior medical scientist expert for SGBM. Furthermore, a second expert in the field analyzed a randomly selected and representative sample size of the reviewed content with an inter-rater reliability (IRR) of 92.50%.

For the quantitative analysis of the respective preparatory material's sex and gender awareness, each AMBOSS learning card and KAPLAN e-book chapter were assessed for the presence of sex- or gender-based aspects with respect to the eight categories: *epidemiology, prevention, pathophysiology, clinical presentation, diagnostics, therapy, prognosis*, and *pregnancy*. A section counted as sex- and gender-aware if there was at least one sex- or gender-based aspect included. After determining each subject's share of sex- and gender-related content, the overall sex- and gender-awareness percentage for every main field was calculated. We used the weighted arithmetic mean of the respective subjects' sex- and gender-awareness scores, considering their differing shares of the overall content.

The second step comprised the qualitative coding of the preparatory material by (1) binary categorization into sex-based aspects (biological differences of women and men) and gender-based aspects (socially constructed traits/characteristics attributed to an individual) and (2) qualification with respect to the presence or absence of a (patho-)physiological explanation for the stated sex or gender differences.

Statistical analysis {#section7-2382120519894253}
--------------------

Descriptive and statistical data analyses were conducted using Microsoft Excel for Macintosh 16.12 and IBM SPSS Statistics 24 (Released 2016; IBM SPSS Statistics for Macintosh, Version 24.0; IBM Corp., Armonk, NY, USA), respectively. Inter-rater reliability was measured as the percent agreement between raters. Data were expressed in percentages for nominal variables. Significance of differences in sex- and gender-related content was calculated using Pearson chi-square test. A *P* value less than .05 was considered statistically significant.

Results {#section8-2382120519894253}
=======

The distribution of the allocated subjects differed slightly between AMBOSS and KAPLAN. The learning material allocated to the category *clinical subjects* was 51.76% in AMBOSS and 35.71% in KAPLAN; 9.41% in AMBOSS and 14.29% in KAPLAN for *behavioral and social science*; and 5.8% in AMBOSS and 14.29% in KAPLAN for *pharmacology*. Subjects which presented with little content or were specific to either AMBOSS or KAPLAN were excluded from the analysis ([Supplementary Table 1](https://journals.sagepub.com/doi/suppl/10.1177/2382120519894253)).

Quantitative analysis of the percentage of sex- and gender-related content of all analyzed subjects showed 84.2% within the *immunology/rheumatology* section of AMBOSS and 50% within the KAPLAN counterpart (*P* \< .1). Sex- or gender-based aspects were mentioned in 35.7% of the AMBOSS learning cards covering the subject *occupational and environmental medicine*. Its counterpart, the KAPLAN chapter *social sciences*, did not contain a single sex- or gender-based aspect (*P* \< .05). Analyzing the *psychiatry* content, 46.9% in AMBOSS, compared to 76.9% of KAPLAN *behavioral science* section, mentioned sex- or gender-based facts (*P* \< .1). For the following subjects, the difference between the percentage of sex- and gender-related content of the AMBOSS and the KAPLAN learning material was less than 10%: *endocrinology*/*endocrine pathology, hepatogastroenterology*/*hepatogastrointestinal pathology, nephrology*/*renal pathology, pneumology*/*respiratory pathology*, and *pharmacology. Epidemiology* was identified as the only subject in both preparatory materials that contained at least one sex- or gender-based aspect in every e-learning card or e-chapter (sex- and gender-awareness of 100%).

In relation to the total content of AMBOSS and KAPLAN ([Table 1](#table1-2382120519894253){ref-type="table"}), the sex- and gender-based share of the AMBOSS clinical subjects e-learning cards was 26.8% (±SD 8.2%) and the KAPLAN counterpart 21.1% (±SD 10.2%). The percentage of sex- and gender-related content within the *behavioral and social science* learning material differed significantly between AMBOSS and KAPLAN (4.4% ± 3.1% vs 10.7% ± 7.5%; *P* = .044). Within the main field *pharmacology*, 3.8% of the AMBOSS learning cards were sex- and gender-aware in comparison to 7.9% of the KAPLAN *pharmacology* chapters, however not significantly different.

###### 

Proportion of sex- and gender-related content of main fields in relation to total content of AMBOSS and KAPLAN.

![](10.1177_2382120519894253-table1)

  Main field                      AMBOSS (100%)   KAPLAN (100%)   *P* value
  ------------------------------- --------------- --------------- ------------------------------------------------------------
  Clinical subjects                                               
   Total content (%)              51.76           35.71           
   S&G-related content (SD%)      26.83 (±8.2)    21.12 (±10.2)   .306
  Behavioral and social science                                   
   Total content (%)              9.41            14.29           
   S&G-related content (SD%)      4.39 (±3.1)     10.71 (±7.5)    .044[\*](#table-fn2-2382120519894253){ref-type="table-fn"}
  Pharmacology                                                    
   Total content (%)              5.88            14.29           
   S&G-related content (%)        3.80            7.87            .341

Abbreviations: S&G, sex and gender; SD, standard deviation.

*P* \< .05.

[Figure 1A](#fig1-2382120519894253){ref-type="fig"} and [B](#fig1-2382120519894253){ref-type="fig"} show the distribution of the sex- and gender-based aspects to the eight categories in the main fields *clinical subjects* and *behavioral and social science*. Approximately half of the sex- and gender-based aspects belonged to the category *epidemiology*. AMBOSS put further emphasis on the categories *clinical presentation, diagnostics*, and *therapy*. KAPLAN, however, focused on *pathophysiology* and *clinical presentation*. Learning material presenting facts concerning *pregnancy* was included in both. In the *clinical subjects* content, the following categories demonstrated significant differences between AMBOSS and KAPLAN: *epidemiology* (48.1% vs 39.7%; *P* = .024), *pathophysiology* (2.5% vs 28.5%; *P* \< .001), *diagnostics* (9.8% vs 3.7%; *P* = .002), *therapy* (5.6% vs 0.7%; *P* = .001), and *pregnancy* (14.3% vs 9.4%; *P* = .045). The *behavioral and social science content* of AMBOSS and KAPLAN differed significantly in the following categories: *pathophysiology* (0% vs 14.6%; *P* = .002) and *diagnostics* (7.0% vs 0%; *P* = .009).

![Distribution of sex- and gender-based aspects to eight categories in the main fields: (A) clinical subjects, (B) behavioral and social science, and (C) pharmacology. Comparison of AMBOSS and KAPLAN.\
\**P* \< .05; †*P* \< .1.](10.1177_2382120519894253-fig1){#fig1-2382120519894253}

The pharmacological content of both AMBOSS and KAPLAN ([Figure 1C](#fig1-2382120519894253){ref-type="fig"}) focused on sex- and gender-based aspects regarding therapy (43.6% vs 58.8%; *P* = .052), including differences in side effects between women and men and special instructions for the medical care of pregnant women, stating particular indications and contraindications.

The overwhelming majority of the sex- and gender-related content in the preparatory material covered sex-based and therefore biological aspects ([Table 2](#table2-2382120519894253){ref-type="table"}). Neither the *clinical subjects* nor the *pharmacology* content of either learning resource contained a single gender-based aspect. With 86.0% and 86.5%, sex-based aspects also predominated in the *behavioral and social science* content of AMBOSS and KAPLAN.

###### 

Qualitative analysis of preparatory material separated according to sex-based aspects and gender-based aspects, comparison of AMBOSS and KAPLAN.

![](10.1177_2382120519894253-table2)

  Main fields                     Preparatory material with S&G-based aspects, n (%)   
  ------------------------------- ---------------------------------------------------- ------------
  Clinical subjects               551 (100)                                            267 (100)
  Sex-based aspects               551 (100)                                            267 (100)
  Gender-based aspects            0 (0)                                                0 (0)
  Behavioral and social science   57 (100)                                             96 (100)
  Sex-based aspects               49 (85.96)                                           83 (86.46)
  Gender-based aspects            8 (14.04)                                            13 (13.54)
  Pharmacology                    78 (100)                                             85 (100)
  Sex-based aspects               78 (100)                                             85 (100)
  Gender-based aspects            0 (0)                                                0 (0)

Abbreviations: S&G: sex and gender.

Most learning cards and texts did not include a detailed pathophysiological explanation for sex or gender differences with a similar distribution pattern between the learning resources ([Table 3](#table3-2382120519894253){ref-type="table"}). The *pharmacology* content contained the biggest share of explained sex- and gender-based aspects with 34.6% for AMBOSS and 23.5% for KAPLAN.

###### 

Qualitative analysis: list of two educational levels of the preparatory material with sex- and gender-related content: (1) with pathophysiological explanation and (2) with no pathophysiological explanation.

![](10.1177_2382120519894253-table3)

  Main fields                     Preparatory material with S&G-based aspects, n (%)   
  ------------------------------- ---------------------------------------------------- -------------
  Clinical subjects               551 (100)                                            267 (100)
  With explanation                96 (17.42)                                           38 (14.23)
  No explanation                  455 (82.58)                                          229 (85.77)
  Behavioral and social science   57 (100)                                             96 (100)
  With explanation                2 (3.51)                                             4 (4.17)
  No explanation                  55 (96.49)                                           92 (95.83)
  Pharmacology                    78 (100)                                             85 (100)
  With explanation                27 (34.62)                                           20 (23.53)
  No explanation                  51 (65.38)                                           65 (76.47)

Abbreviations: S&G, sex and gender.

Discussion {#section9-2382120519894253}
==========

The results indicate that the preparatory materials frequently used for preparing for the German and the American national medical exams contain sex- and gender-related content. Nevertheless, there is a lack of quantity and quality in regard to covering SGBM topics.

The main findings of the data analysis are as follows: (1) the overall lack of explicitly gender-related content in AMBOSS and KAPLAN, (2) the lack of a higher educational level regarding the comprised sex- and gender-based aspects in both preparatory materials, and (3) the significantly higher share of sex- and gender-related content incorporated in the main field *behavioral and social science* in KAPLAN compared to AMBOSS.

The vast majority of the included SGBM aspects in both learning materials comprised sex differences. This imbalance between biological facts (sex) and gender-based content (sociocultural aspects) could be explained by the challenge of measuring gender accurately. The study by Pelletier et al^[@bibr6-2382120519894253]^ laid the groundwork for the objective measurement of gender. They ranked patients having suffered from premature acute coronary syndrome on a masculinity/femininity-continuum according to their answers to a detailed questionnaire on sociocultural (gender) determinants (eg, income, education, social networks, environment, health literacy, cultural values), thus determining an individual's gender score in addition to an individual's biological sex. When implemented in clinical trials, this questionnaire will support and advance further research on sociocultural risk factors for diseases, and the obtained findings could lead to new gender-based preventive approaches.

Nevertheless, there are already sex- and gender-based facts that should be added as soon as possible to the exam questions pool. For example, atrial fibrillation increases embolic risk in women more than in men. Thus, at a societal level, women bear a greater burden of stroke than men.^[@bibr14-2382120519894253][@bibr15-2382120519894253]-[@bibr16-2382120519894253]^ Heart failure (HF) is commonly associated with reduced ejection fraction (HFREF). However, this connection is predominantly found in men, whereas women more often suffer from HF with preserved ejection fraction (HFPEF).^[@bibr17-2382120519894253][@bibr18-2382120519894253]-[@bibr19-2382120519894253]^ These symptoms occur based on diastolic dysfunction. Increased arterial pulse wave velocity (PWV ⩽ 9.7 m/s) and waist circumference \>80 cm in postmenopausal women are associated with an increased risk of myocardial diastolic dysfunction.^[@bibr20-2382120519894253]^ Peripartum cardiomyopathy is a potentially life-threatening condition with multiple predisposing factors.^[@bibr21-2382120519894253]^ Therefore, it should be added to the exam topics as well. Diabetes is a stronger risk factor for vascular disease in women than in men.^[@bibr22-2382120519894253]^ Clinical presentation of systemic lupus erythematosus differs between women and men.^[@bibr23-2382120519894253][@bibr24-2382120519894253]-[@bibr25-2382120519894253]^ Women present with earlier onset of disease and more frequent relapses of multiple sclerosis (MS). However, progression is faster, and outcome is worse in men with MS.^[@bibr26-2382120519894253],[@bibr27-2382120519894253]^ A lot more evidence-based facts should be included in the exam questions pool. For additional information and literature on these facts, please refer to [Table 4](#table4-2382120519894253){ref-type="table"} highlighting knowledge gaps by way of example.

###### 

Examples of sex- and gender-related content identified in selected sections, facts not included in the learning materials, and knowledge gaps identified for future research.

![](10.1177_2382120519894253-table4)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Pathology                                                                                                                                                                                     AMBOSS                                                                                                                                                      KAPLAN                                                                                                                                                          FACTS not included and KNOWLEDGE GAPS
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cardiology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

   Atrial fibrillation (AF)                                                                                                                                                                     Epidemiology: M \> F                                                                                                                                                                                                                                                                                                        More women than men live with atrial fibrillation because of age dependency and greater longevity in women. Atrial fibrillation increases embolic risk more in women than in men.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Women with stroke are more likely to have atrial fibrillation (leading to embolic stroke) and hypertension than men with stroke.^[@bibr14-2382120519894253]^ Adjusted data do suggest a lower case fatality in women.^[@bibr15-2382120519894253]^ Thus, at a societal level, women bear a greater burden of stroke than men, largely driven by their longer life expectancy and the higher risk of stroke with advancing age.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            In AF patients, female sex is associated with an age-dependent moderate risk of stroke and should be regarded as a stroke risk modifier relevant in the presence of other CHA2DS2-VASc risk stroke factors, rather than an independent stroke risk factor.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            AF patients aged \<65 years, with a CHA2DS2-VASc score of 1 due to female sex have low annual stroke rates (generally \<1%) and do not need any antithrombotic therapy.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Women with AF and ⩾1 additional stroke risk factor (ie, with a CHA2DS2-VASc score of ⩾2) should be considered for OAC.^[@bibr16-2382120519894253]^

  Prognosis: CHA2DS2-VASc score for estimating the risk of stroke in patients with AF, Sc = sex category (ie, female sex)                                                                                                                                                                                                                                                                                                                                                                                                   

   Dilated cardiomyopathy (DCM)                                                                                                                                                                 Epidemiology: M: F = 3:1                                                                                                                                                                                                                                                                                                    Epidemiology data based on traditional definition of heart failure with reduced ejection fraction (HFREF).\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Female and male patients with HF who are treated in European hospitals differ in terms of clinical manifestations. In the Euro Heart failure survey, systolic HF, known as HF with reduced ejection fraction (HFREF), was found predominantly in men, whereas women presented with HF with preserved (normal) ejection fraction (HFPEF) or diastolic HF.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            DCM is a heterogeneous condition manifest in a diverse group of patients due to a combination of underlying genetic susceptibility and environmental insults.^[@bibr28-2382120519894253]^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Women with DCM have better survival compared to men, which may partly be due to less severe left ventricular dysfunction and a smaller scar burden.^[@bibr29-2382120519894253]^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Takotsubo CMP (TTC):\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Initial clinical presentation of TTC often mimics ST-elevation myocardial infarction (STEMI), including acute chest pain, ST-segment elevation, and raised cardiac biomarkers.^[@bibr30-2382120519894253]^ TTC mostly occurs in postmenopausal women and has been associated with acute stress, smoking, alcohol abuse, and hypercholesterolemia.^[@bibr31-2382120519894253]^ It is yet unclear why TTC is more often observed in women.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Peripartum Cardiomyopathy (PPCM) is a potentially life-threatening condition typically presenting as heart failure with reduced ejection fraction (HFREF) in the last month of pregnancy or in the months following delivery in women without another known cause of heart failure. Predisposing factors for PPCM seem to be multiparity and multiple pregnancies, family history, ethnicity, smoking, diabetes, hypertension, pre-eclampsia, malnutrition, age of mother (with older mothers being at greater risk), and prolonged use of tocolytic beta-agonists.^[@bibr21-2382120519894253]^

                                                                                                                                                                                                Pregnancy: some cases are related to pregnancy                                                                                                                                                                                                                                                                              

   Ischemic Heart Disease                                                                                                                                                                       Epidemiology: M \> F (2:1)                                                                                                                                  Epidemiology: cardiac ischemia is most often seen in middle-aged men and postmenopausal women                                                                   Epidemiology data based on traditional pathophysiology with catheter-based obstruction of main coronary arteries. In women, more often ischemic heart diseases without obstruction of the main coronary arteries occur because of heterogeneous diseases and/or microvascular dysfunction, known as INOCA (myocardial ischemia with no obstructive coronary arteries)^[@bibr32-2382120519894253]^ and MINOCA (myocardial infarction with nonobstructed coronary arteries).^[@bibr33-2382120519894253]^

  Clinical presentation: frequently only retrosternal "pressure" (as opposed to pain) in women, exclusively unspecific vegetative symptoms possible                                             Clinical presentation: atypical presentation of myocardial infarction with little or no chest pain is seen most frequently in women                                                                                                                                                                                         

  Endocrinology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

   Diabetes mellitus                                                                                                                                                                            Clinical presentation: urogenital---erectile dysfunction                                                                                                    Clinical presentation: diabetic neuropathy can cause sexual impotence                                                                                           Diabetes is a stronger risk factor for vascular disease in women than men.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Diabetes confers a 44% greater excess risk of coronary heart disease (CHD) and a 27% greater excess risk of stroke in women than in men, independent of sex differences in other major risk factors.^[@bibr22-2382120519894253]^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            *Knowledge gap*:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            *The evidence is incomplete and the reasons behind women's excess vascular relative risk from diabetes are not fully understood. Further research is therefore needed to provide further insights.*

  Pregnancy: gestational diabetes, a glucose tolerance disorder arising or being diagnosed for the first time during pregnancy                                                                                                                                                                                                                                                                                                                                                                                              

   Graves disease                                                                                                                                                                               Epidemiology: F \> M (5:1)                                                                                                                                  Epidemiology: women are affected more frequently than men                                                                                                       Thyroid diseases afflict far more women than men. Hypothyroidism and hyperthyroidism are about 10 times more common in women than in men. Thyroid nodules and thyroid cancer are about three times more common in women than in men.^[@bibr34-2382120519894253]^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Men treated with antithyroid drugs had fewer adverse events (9% vs 18%) and treatment discontinuation (5% vs 16%) compared to women.^[@bibr35-2382120519894253]^

  Diagnostics: enlarged thyroid gland (F \> 18 mL, M \> 25 mL)                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Hepatogastroenterology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

   Cholelithiasis                                                                                                                                                                               Epidemiology: 6 F mnemonic for risk factors: "fair (white), family (positive family history), fat (BMI \> 30), woman, fertile, forty (age ⩾ 40 years)"      Epidemiology: risk factors for cholesterol stones include female gender, pregnancy, oral contraceptives, and hormone replacement therapy                        *New sex and gender sensitive facts are missing*

   Chronic pancreatitis                                                                                                                                                                                                                                                                                                                                     Epidemiology: it is common in middle-aged male alcoholics                                                                                                       Clinical presentation: men have a 40% higher risk of developing diabetes (associated with diseases of the exocrine pancreas) than women.^[@bibr36-2382120519894253]^

   Hereditary nonpolyposis colorectal cancer (HNPCC)                                                                                                                                            Clinical presentation: increased risk of cancer at other sites: endometrial cancer (40%-60% of affected women) and ovarian cancer (10% of affected women)   Clinical presentation: it is associated with an increased risk of cancer at other sites, including the endometrium and the ovary                                *New sex and gender sensitive facts are missing*

  Prevention: annual gynecological exams including transvaginal sonography for affected women aged 25 years and older; annual endometrial biopsies for affected women aged 35 years and older                                                                                                                                                                                                                                                                                                                               

  Immunology/rheumatology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

   Scleroderma (progressive systemic sclerosis)                                                                                                                                                 Epidemiology: F \> M (3:1)                                                                                                                                  Epidemiology: it affects women more than men                                                                                                                    Sex ratio of women to men with SSc prior to menopause is estimated at 15:1, while it lowers to 2.4:1 after menopause.^[@bibr37-2382120519894253]^

  Prognosis: Men have a poorer prognosis than women                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

   Sjögren syndrome (sicca syndrome)                                                                                                                                                            Epidemiology: F \> M (10:1), especially women during menopause                                                                                              Epidemiology: women are affected more often than men                                                                                                            *New sex and gender sensitive facts are missing*

   Systemic lupus erythematosus (SLE)                                                                                                                                                           Epidemiology: F \> M (10:1)                                                                                                                                 Epidemiology: women are affected much more often than men (F:M = 9:1)                                                                                           Alopecia, photosensitivity, oral ulcers, arthritis, malar rash, lupus anticoagulant level, and low level of C3 were significantly higher in female lupus patients, whereas renal involvement, serositis and pleurisies, thrombocytopenia, and anti-double-stranded deoxyribonucleic acid level were predominant in male patients with SLE.^[@bibr25-2382120519894253]^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            The primary cause of mortality in female patients with SLE is cardiovascular disease.^[@bibr24-2382120519894253]^ Hypertension, thrombosis, and embolism have high prevalence rates in these women.^[@bibr23-2382120519894253]^

  Nephrology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

   IgA nephropathy (Berger disease)                                                                                                                                                             Epidemiology: risk factors for an unfavorable course include "men under the age of 30 years"                                                                Epidemiology: it affects children and young adults, mostly men                                                                                                  *New sex and gender sensitive facts are missing*

   Pyelonephritis                                                                                                                                                                               Epidemiology: F \> M                                                                                                                                        Epidemiology: it affects women much more than men, but the incidence increases in older men with prostatic hyperplasia                                          *New sex and gender sensitive facts are missing*

   Urinary tract infection (UTI)                                                                                                                                                                Epidemiology: predisposing factors include female sex; a UTI in men always requires further investigation                                                   Epidemiology: clinically, it affects women far more than men; predisposing factors include benign prostatic hypertrophy and cystocele                           *New sex and gender sensitive facts are missing*

  Diagnostics: every suspicion of an UTI is indication for a urine culture, except in women with uncomplicated UTIs                                                                                                                                                                                                                                                                                                                                                                                                         

   Urolithiasis                                                                                                                                                                                 Epidemiology: M \> F                                                                                                                                        Epidemiology: men are affected more often than women                                                                                                            *New sex and gender sensitive facts are missing*

  Neurology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

   Meningioma                                                                                                                                                                                   Epidemiology: F \> M (3:2)                                                                                                                                  Epidemiology: it is common in adults, F \> M                                                                                                                    *New sex and gender sensitive facts are missing*

   Multiple sclerosis (MS)                                                                                                                                                                      Epidemiology: F \> M (2:1), typically young women                                                                                                           Epidemiology: women have two times the risk of men                                                                                                              Gender differences include earlier disease onset and more frequent relapses in women and faster progression and worse outcomes in men.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Hormone-related physiological conditions in women such as puberty, pregnancy, puerperium, and menopause also exert significant influence both on disease prevalence and on outcomes.^[@bibr27-2382120519894253]^\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            *Knowledge gap*:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            *To date, however, due to a lack of systematic studies on treatment responses in males versus females, evidence in this area is still sparse. We argue that studies taking sex differences into account could pave the way for sex-specific and therefore personalized treatment.*^[@bibr26-2382120519894253]^

   Myasthenia gravis                                                                                                                                                                            Epidemiology: F \> M (3:2); two peaks in frequency between age 30 and 40 years (more women) and age 60 and 80 years (more men)                              Epidemiology: women are affected more frequently than men                                                                                                       *New sex and gender sensitive facts are missing*

  Clinical presentation: symptoms often increase during menstruation                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Pneumology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

   Lung cancer                                                                                                                                                                                  Epidemiology: M \> F (3:1); leading cause of death among both men and women; second most common carcinoma in men and third most common carcinoma in women   Epidemiology: lung cancer is the leading cause of death among both men and women; it has been increasing in women (increased smoking) in the past few decades   *New sex and gender sensitive facts are missing*

  Epidemiology: squamous cell carcinoma is the most common non-small-cell lung carcinoma (NSCLC) in men (45%); adenocarcinoma is the most common NSCLC in women (40%)                           Epidemiology: adenocarcinoma is more commonly seen in women; squamous cell carcinoma and small-cell carcinoma affect men more than women                                                                                                                                                                                    

   Sarcoidosis                                                                                                                                                                                  Epidemiology: over all F = M; especially young women are affected by Löfgren syndrome                                                                       Epidemiology: the disease affects women more than men                                                                                                           *New sex and gender sensitive facts are missing*

   Tuberculosis                                                                                                                                                                                 Epidemiology: M \> F                                                                                                                                                                                                                                                                                                        *New sex and gender sensitive facts are missing*

  Clinical presentation: urogenital tuberculosis in men (e.g. prostatitis) and women (eg, adnexitis)                                                                                            Clinical presentation: sites that may become involved include fallopian tubes and epididymis                                                                                                                                                                                                                                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: BMI, body mass index; F, female; M, male; ml, milliliter; S&G, sex & gender; SSc, systemic sclerosis.

Epidemiological sex- and gender-based aspects accounted for a large number of the total amount of detected data. The predominant absence of pathophysiological explanations for sex and gender differences supports the conclusion that sex- and gender-related content only serves as additional information. This could be caused by a lack of scientific evidence in regard to the pathophysiological mechanisms underlying the influence of sex and gender on health and disease or a lack of prioritization of sex- and gender-related knowledge in the preparatory materials and the respective standardized examinations.

Medical curricula emphasize so-called "hot topics" (areas considered of special importance by the accrediting body for medical schools in the United States and Canada), defined by the Liaison Committee on Medical Education.^[@bibr38-2382120519894253]^ In Germany, medical curricula should be based on the National Competency--based Learning Objective Catalog Medicine (NKLM). It is a competence-based core curriculum with a recommendation character (<https://review.nklm.de/zend/>).

Hochleitner et al^[@bibr39-2382120519894253]^ observed a discrepancy between the amount of evidence provided by sex- and gender-based research and its integration into conventional learning resources, which still consider the male body and physiology as the norm. Lack of support and guidance on an institutional (ie, medical faculties) and a governmental level (ie, compulsory guidelines) were considered influencing factors on the failure of a systematic SGBM implementation in medical education.

In accordance with the predominantly epidemiological data findings in this study, Song et al^[@bibr40-2382120519894253]^ found most of the sex- and gender-related content in their analysis on sex and gender of the Texas Tech University Health Sciences Center™ School of Medicine's curriculum to be either of epidemiological nature or anatomy- and physiology-related. They discovered only incomplete coverage of many of the sex- and gender-based topics, which correlates with our finding that the analyzed preparatory materials rarely offered pathophysiological explanations for sex- and gender-based aspects. In a national student survey conducted by Jenkins et al,^[@bibr41-2382120519894253]^ clinical subjects such as endocrinology, rheumatology, cardiology, and pulmonology were considered to be covered moderately to extensively in regard to SGBM. However, more than half of the participants did not feel well prepared for transferring this sex- and gender-related knowledge into clinical practice.

As long as the implementation of sex- and gender-based medicine knowledge is not systematically integrated into the training and is not sufficiently taken into account in the exam questions, the students could only turn to alternative resources such as eGender, a web-based interactive knowledge sharing platform for sex- and gender-based medical education.^[@bibr42-2382120519894253]^

The comparison of the preparatory materials provided evidence to support the conclusion that KAPLAN had a significantly higher share of sex- and gender-related content in the main field *behavioral and social science*, probably due to the two countries' differing approaches for addressing socioeconomic aspects within the medical curriculum. In the United States, *behavioral and social science* is considered an independent subject within medical education. In contrast, German medical curricula often integrate socioeconomical aspects of health and disease into a clinical subject's syllabus, reflected in the lack of sex- and gender-related content in the main field *behavioral and social science* in AMBOSS.

Limitations {#section10-2382120519894253}
-----------

This study only investigated two distinct preparatory materials. While they are popular among medical students, there are also other commercial learning resources available. Nevertheless, AMBOSS and KAPLAN aim to offer a comprehensive preparation for the German state examination and the USMLE Step 1, respectively, and are both geared toward those standard examinations. Furthermore, we focused on a selection of subjects and did not include all subjects in our analysis to increase comparability between the two preparatory materials.

Conclusions {#section11-2382120519894253}
===========

The sex- and gender-related content of the preparatory materials focuses almost exclusively on biological sex differences. Gender is an important influencing factor on health and disease that should be further integrated into the preparatory materials for national medical exams. The supplemental character of the gender-based content in learning resources fails to reflect the importance of SGBM as an integral component of patient-centered medicine.
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